C12N 2501/39
Steroid hormones
C12N2501/39 (Steroid hormones) appears on 728 US grants and 1,158 published applications in this corpus.
Search patents in C12N- Granted patents
- 728
- Published applications
- 1,158
- Assignees
- 630
- Inventors
- 2,222
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 8 | 0 |
| 1995 | 9 | 0 |
| 1996 | 15 | 0 |
| 1997 | 24 | 0 |
| 1998 | 32 | 0 |
| 1999 | 25 | 0 |
| 2000 | 23 | 0 |
| 2001 | 15 | 8 |
| 2002 | 18 | 43 |
| 2003 | 21 | 45 |
| 2004 | 12 | 44 |
| 2005 | 17 | 48 |
| 2006 | 23 | 44 |
| 2007 | 14 | 34 |
| 2008 | 16 | 47 |
| 2009 | 19 | 53 |
| 2010 | 16 | 42 |
| 2011 | 24 | 38 |
| 2012 | 31 | 44 |
| 2013 | 26 | 41 |
| 2014 | 16 | 52 |
| 2015 | 25 | 41 |
| 2016 | 27 | 45 |
| 2017 | 33 | 48 |
| 2018 | 20 | 44 |
| 2019 | 33 | 61 |
| 2020 | 25 | 53 |
| 2021 | 30 | 44 |
| 2022 | 35 | 51 |
| 2023 | 23 | 52 |
| 2024 | 18 | 49 |
| 2025 | 16 | 45 |
| 2026 | 18 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures15 Sep 2026US 12,734,197 B2Wisconsin Alumni Research Foundation
- Method for the in vitro or ex vivo amplification of human adipose tissue stem cells1 Sep 2026US 12,723,234 B2Centre National de la Recherche Scientifique (CNRS)
- Method for culturing gynaecological tumour primary cells and matching culture medium25 Aug 2026US 12,716,057 B2Genex Health Co., Ltd
- Methods for engineering allogeneic and highly active T cell for immunotheraphy14 Jul 2026US 12,680,076 B2Cellectis
- In vitro culturing method for inducing ovarian follicles from fetal ovarian cells of primate8 Oct 2026US 2026/0308531 A1Kyoto University
- Composition containing extracellular matrix and matrix-bound vesicles for producing extracellular matrix and preparation method therefor24 Sep 2026US 2026/0286308 A1Hlb Cell Co., Ltd
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes24 Sep 2026US 2026/0286311 A1Satellite Biosciences, Inc.
- Thyrocytes and uses thereof17 Sep 2026US 2026/0275279 A1LifeNet Health
- Metabolic selection for glycogen-storing cells in vitro3 Sep 2026US 2026/0258368 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Human mesenchymal stem cells813US 5,486,359 AOsiris Therapeutics, Inc. · 1996
- Method for treating connective tissue disorders633US 5,226,914 A1993
- Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration549US 6,200,606 B1DePuy Orthopaedics, Inc. · 2001
- Connective tissue regeneration using human mesenchymal stem cell preparations470US 5,811,094 AOsiris Therapeutics, Inc. · 1998
- Protein-free culture medium464US 4,767,704 AColumbia University in the City of New York · 1988